Periodic Reporting for period 2 - MAP-AD (A multimodal approach to accelerate drug discovery and development in Alzheimer’s disease)

Alzheimer’s disease (AD) is a major societal challenge, impacting up to one-third of the population over 85 years old. The European Commission and various international bodies have repeatedly fostered research initiatives to prevent the development or stem the progression of...